Rising Demand for Orthopedic Drugs Drives Market Growth at 4.7% CAGR Through 2034
According to a new report from Intel Market Research , the global prescription orthopedic drugs market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.1 billion by 2034 , growing at a steady CAGR of 4.7% during the forecast period (2026–2034). This sustained growth reflects an aging global population's increasing need for musculoskeletal treatments and continuous therapeutic advancements. What Are Prescription Orthopedic Drugs? Prescription orthopedic drugs represent specialized pharmaceutical treatments targeting musculoskeletal disorders including arthritis, osteoporosis, gout , and post-surgical pain management . These medications encompass multiple therapeutic categories such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic agents designed to combat joint degeneration and inflammation. The market's evolution demonstrates how pharmaceutical innovation addresses grow...